OrbiMed's Biopharma Portfolio

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO).

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.

resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.